Oxford, UK, 27 May 2025 – Nucleome Therapeutics (‘Nucleome’ or ‘the Company’), a biotechnology

company harnessing the power of non-coding human genetics to discover first-in-class antibody

treatments for inflammatory diseases, announces it has appointed Bhavna Hunjan as Chief Business

Officer with immediate effect.

Video explaining how Nucleome Therapeutics are developing breakthrough genomics technologies focussed on discovering the molecular basis of inflammatory disease to bring first-in-class medicines to patients.

Tasnia Chowdhury • Kirsty Waddington • Wiktoria Jozefowska • Neil Ashley • Gabriela Pirgova • Chantal Hargreaves • James Heward • Neil Stokes • Rachael Nimmo • Stephen Harrison